This comprehensive report provides a strategic analysis of the Global Human Fibrinogen Market, covering current status, growth trajectories, and competitive landscapes from 2024 through 2036.
Human Fibrinogen is a high-value plasma-derived glycoprotein essential for hemostasis. As a primary clotting factor (Factor I), it is converted into fibrin to form stable blood clots. The market is characterized by a high degree of technical consolidation and rigorous regulatory oversight. Valued at approximately USD 470 million in 2017, the market is poised for explosive growth, targeting USD 2,820 million by 2036, driven by a projected CAGR of 25.0% during the forecast period.
Human Fibrinogen Concentrate (Lyophilized): The gold standard for rapid restoration of fibrinogen levels in acute bleeding.
Fibrin Sealant Kits: Dual-component systems (Fibrinogen + Thrombin) used for topical hemostasis and tissue sealing.
Purified Plasma-derived Fibrinogen: Used primarily in research and specialized clinical diagnostics.
Congenital Fibrinogen Deficiency: Treatment for rare disorders such as Afibrinogenemia and Hypofibrinogenemia.
Acquired Fibrinogen Deficiency (Trauma & Surgery): The fastest-growing segment, used in cardiac surgery, postpartum hemorrhage (PPH), and orthopedic procedures.
Liver Disease & Critical Care: Management of coagulopathy in patients with end-stage liver disease.
North America: Holds the largest revenue share due to high diagnosis rates for bleeding disorders and advanced surgical infrastructures in the US and Canada.
Europe: A mature market led by industry giants like CSL Behring and LFB. Strong emphasis on "Patient Blood Management" (PBM) protocols drives steady demand.
China: Represents the most significant growth opportunity. Large-scale domestic players (Shanghai RAAS, Hualan Bio) are expanding plasma collection capacities to meet localized demand.
Asia-Pacific (Ex-China): Significant growth in India and Southeast Asia due to rising surgical volumes and improving healthcare access.
Bargaining Power of Suppliers (High): Raw material (human plasma) is scarce and subject to strict collection regulations.
Bargaining Power of Buyers (Moderate): Hospitals and Group Purchasing Organizations (GPOs) have some leverage, but the life-saving nature of the product limits price sensitivity.
Threat of New Entrants (Very Low): Barriers include astronomical R&D costs, the need for extensive plasma collection networks, and stringent FDA/EMA approval processes.
Threat of Substitutes (Low): Recombinant fibrinogen is under development but currently lacks the cost-effectiveness and clinical ubiquity of plasma-derived versions.
Competitive Rivalry (High): Dominated by an oligopoly of global leaders competing on purity, safety (viral inactivation), and supply chain reliability.
Strengths: Essential life-saving product; high clinical efficacy; established safety profiles.
Weaknesses: High production costs; dependence on human donors; limited shelf life compared to synthetic drugs.
Opportunities: Expansion into emergency trauma care (Pre-hospital use); development of "Ready-to-use" liquid formulations.
Threats: Potential for pathogen transmission (though minimized by modern tech); stringent price controls in emerging markets.
The market is led by top-tier biopharmaceutical companies with extensive plasma fractionation capabilities:
| Manufacturer | Core Focus | Official Website |
| CSL Behring | Global Leader in Plasma Protein Biotherapies | Visit Website |
| LFB Group | Hemostasis and Intensive Care Specialists | Visit Website |
| Shanghai RAAS | China’s Leading Plasma Fractionator | Visit Website |
| Octapharma | Global Human Protein Manufacturer | Visit Website |
| Takeda (Shire/Baxalta) | Rare Disease and Hematology Innovation | Visit Website |
| Grifols | Global Leader in Plasma Collection & Processing | Visit Website |
| Hualan Biological | Major Chinese Biological Product Producer | Visit Website |
| Kedrion Biopharma | International Plasma Derivative Specialist | Visit Website |
| Boya Bio-Pharmaceutical | Integrated Blood Product Manufacturer | Visit Website |
| GC Pharma (Green Cross) | Leading Biopharma in South Korea | Visit Website |
Point-of-Care (POC) Integration: Increasing use of Thromboelastometry (ROTEM/TEG) to guide goal-directed fibrinogen replacement in operating rooms.
Plasma Collection Automation: Implementation of AI and automated plasmapheresis to increase donor yield and efficiency.
Consolidation: Large players are acquiring regional plasma centers to secure the upstream supply chain.
Driver: The rising geriatric population requiring complex cardiovascular and orthopedic surgeries.
Driver: Increased awareness and screening for congenital bleeding disorders in developing nations.
Challenge: The "Plasma Gap"—global demand for plasma often outstrips the supply from voluntary and paid donations.
Challenge: Complex regulatory landscape for cross-border biological product distribution.
Upstream: Plasma collection (Donation centers) and testing for viral markers.
Midstream: Cold-chain logistics to fractionation facilities; protein separation (Cohn process/Chromatography); viral inactivation.
Downstream: Fill-finish (Lyophilization); stringent quality control; distribution to hospitals and trauma centers.
For Manufacturers: Focus on Viral Inactivation Technology to differentiate product safety profiles and secure "high-end" market share.
For New Entrants: Avoid the generic human fibrinogen market unless backed by a robust, pre-existing plasma collection network.
For Investors: Look toward companies developing Recombinant Fibrinogen, as this represents the next technological frontier to bypass human donor dependency.
For Hospitals: Adopt Goal-Directed Therapy protocols to optimize fibrinogen usage and reduce overall patient costs.
Table of Contents
Global Human Fibrinogen Market Professional Survey Report
1 Industry Overview of Human Fibrinogen
1.1 Definition and Specifications of Human Fibrinogen
1.1.1 Definition of Human Fibrinogen
1.1.2 Specifications of Human Fibrinogen
1.2 Classification of Human Fibrinogen
1.2.1 Pure Human Fibrinogen
1.2.2 Fibrinogen Concentrate (Human)
1.3 Applications of Human Fibrinogen
1.3.1 Congenital Fibrinogen Deficiency
1.3.2 Surgical Procedures
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 Europe
1.4.3 China
1.4.4 Japan
1.4.5 Southeast Asia
1.4.6 India
2 Manufacturing Cost Structure Analysis of Human Fibrinogen
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Human Fibrinogen
2.3 Manufacturing Process Analysis of Human Fibrinogen
2.4 Industry Chain Structure of Human Fibrinogen
3 Technical Data and Manufacturing Plants Analysis of Human Fibrinogen
3.1 Capacity and Commercial Production Date of Global Human Fibrinogen Major Manufacturers in
3.2 Manufacturing Plants Distribution of Global Human Fibrinogen Major Manufacturers in
3.3 R&D Status and Technology Source of Global Human Fibrinogen Major Manufacturers in
3.4 Raw Materials Sources Analysis of Global Human Fibrinogen Major Manufacturers in
4 Global Human Fibrinogen Overall Market Overview
4.1 -E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 -E Global Human Fibrinogen Capacity and Growth Rate Analysis
4.2.2 Human Fibrinogen Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 -E Global Human Fibrinogen Sales and Growth Rate Analysis
4.3.2 Human Fibrinogen Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 -E Global Human Fibrinogen Sales Price
4.4.2 Human Fibrinogen Sales Price Analysis (Company Segment)
5 Human Fibrinogen Regional Market Analysis
5.1 North America Human Fibrinogen Market Analysis
5.1.1 North America Human Fibrinogen Market Overview
5.1.2 North America -E Human Fibrinogen Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America -E Human Fibrinogen Sales Price Analysis
5.1.4 North America Human Fibrinogen Market Share Analysis
5.2 Europe Human Fibrinogen Market Analysis
5.2.1 Europe Human Fibrinogen Market Overview
5.2.2 Europe -E Human Fibrinogen Local Supply, Import, Export, Local Consumption Analysis
5.2.3 Europe -E Human Fibrinogen Sales Price Analysis
5.2.4 Europe Human Fibrinogen Market Share Analysis
5.3 China Human Fibrinogen Market Analysis
5.3.1 China Human Fibrinogen Market Overview
5.3.2 China -E Human Fibrinogen Local Supply, Import, Export, Local Consumption Analysis
5.3.3 China -E Human Fibrinogen Sales Price Analysis
5.3.4 China Human Fibrinogen Market Share Analysis
5.4 Japan Human Fibrinogen Market Analysis
5.4.1 Japan Human Fibrinogen Market Overview
5.4.2 Japan -E Human Fibrinogen Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Japan -E Human Fibrinogen Sales Price Analysis
5.4.4 Japan Human Fibrinogen Market Share Analysis
5.5 Southeast Asia Human Fibrinogen Market Analysis
5.5.1 Southeast Asia Human Fibrinogen Market Overview
5.5.2 Southeast Asia -E Human Fibrinogen Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Southeast Asia -E Human Fibrinogen Sales Price Analysis
5.5.4 Southeast Asia Human Fibrinogen Market Share Analysis
5.6 India Human Fibrinogen Market Analysis
5.6.1 India Human Fibrinogen Market Overview
5.6.2 India -E Human Fibrinogen Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India -E Human Fibrinogen Sales Price Analysis
5.6.4 India Human Fibrinogen Market Share Analysis
6 Global -E Human Fibrinogen Segment Market Analysis (by Type)
6.1 Global -E Human Fibrinogen Sales by Type
6.2 Different Types of Human Fibrinogen Product Interview Price Analysis
6.3 Different Types of Human Fibrinogen Product Driving Factors Analysis
6.3.1 Pure Human Fibrinogen Growth Driving Factor Analysis
6.3.2 Fibrinogen Concentrate (Human) Growth Driving Factor Analysis
7 Global -E Human Fibrinogen Segment Market Analysis (by Application)
7.1 Global -E Human Fibrinogen Consumption by Application
7.2 Different Application of Human Fibrinogen Product Interview Price Analysis
7.3 Different Application of Human Fibrinogen Product Driving Factors Analysis
7.3.1 Congenital Fibrinogen Deficiency of Human Fibrinogen Growth Driving Factor Analysis
7.3.2 Surgical Procedures of Human Fibrinogen Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Human Fibrinogen
8.1 CSL Behring
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 CSL Behring Human Fibrinogen Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 CSL Behring Human Fibrinogen Business Region Distribution Analysis
8.2 LFB
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 LFB Human Fibrinogen Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 LFB Human Fibrinogen Business Region Distribution Analysis
8.3 Shanghai RAAS
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Shanghai RAAS Human Fibrinogen Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Shanghai RAAS Human Fibrinogen Business Region Distribution Analysis
8.4 Boya
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Boya Human Fibrinogen Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Boya Human Fibrinogen Business Region Distribution Analysis
8.5 Hualan Biological Engineering
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 Hualan Biological Engineering Human Fibrinogen Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Hualan Biological Engineering Human Fibrinogen Business Region Distribution Analysis
8.6 Harbin Pacific Biopharmaceutical
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 Harbin Pacific Biopharmaceutical Human Fibrinogen Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Harbin Pacific Biopharmaceutical Human Fibrinogen Business Region Distribution Analysis
8.7 Greencross
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 Greencross Human Fibrinogen Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Greencross Human Fibrinogen Business Region Distribution Analysis
8.8 Shanghai XinXing Medical
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Product A
8.8.2.2 Product B
8.8.3 Shanghai XinXing Medical Human Fibrinogen Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Shanghai XinXing Medical Human Fibrinogen Business Region Distribution Analysis
9 Development Trend of Analysis of Human Fibrinogen Market
9.1 Global Human Fibrinogen Market Trend Analysis
9.1.1 Global -2025 Human Fibrinogen Market Size (Volume and Value) Forecast
9.1.2 Global -2025 Human Fibrinogen Sales Price Forecast
9.2 Human Fibrinogen Regional Market Trend
9.2.1 North America -2025 Human Fibrinogen Consumption Forecast
9.2.2 Europe -2025 Human Fibrinogen Consumption Forecast
9.2.3 China -2025 Human Fibrinogen Consumption Forecast
9.2.4 Japan -2025 Human Fibrinogen Consumption Forecast
9.2.5 Southeast Asia -2025 Human Fibrinogen Consumption Forecast
9.2.6 India -2025 Human Fibrinogen Consumption Forecast
9.3 Human Fibrinogen Market Trend (Product Type)
9.4 Human Fibrinogen Market Trend (Application)
10 Human Fibrinogen Marketing Type Analysis
10.1 Human Fibrinogen Regional Marketing Type Analysis
10.2 Human Fibrinogen International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Human Fibrinogen by Region
10.4 Human Fibrinogen Supply Chain Analysis
11 Consumers Analysis of Human Fibrinogen
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
12 Conclusion of the Global Human Fibrinogen Market Professional Survey Report
Methodology
Analyst Introduction
Data Source
List of Tables and Figures
Figure Picture of Human Fibrinogen
Table Product Specifications of Human Fibrinogen
Table Classification of Human Fibrinogen
Figure Global Production Market Share of Human Fibrinogen by Type in
Figure Pure Human Fibrinogen Picture
Table Major Manufacturers of Pure Human Fibrinogen
Figure Fibrinogen Concentrate (Human) Picture
Table Major Manufacturers of Fibrinogen Concentrate (Human)
Table Applications of Human Fibrinogen
Figure Global Consumption Volume Market Share of Human Fibrinogen by Application in
Figure Congenital Fibrinogen Deficiency Examples
Table Major Consumers in Congenital Fibrinogen Deficiency
Figure Surgical Procedures Examples
Table Major Consumers in Surgical Procedures
Figure Market Share of Human Fibrinogen by Regions
Figure North America Human Fibrinogen Market Size (Million USD) (-2025)
Figure Europe Human Fibrinogen Market Size (Million USD) (-2025)
Figure China Human Fibrinogen Market Size (Million USD) (-2025)
Figure Japan Human Fibrinogen Market Size (Million USD) (-2025)
Figure Southeast Asia Human Fibrinogen Market Size (Million USD) (-2025)
Figure India Human Fibrinogen Market Size (Million USD) (-2025)
Table Human Fibrinogen Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Human Fibrinogen in
Figure Manufacturing Process Analysis of Human Fibrinogen
Figure Industry Chain Structure of Human Fibrinogen
Table Capacity and Commercial Production Date of Global Human Fibrinogen Major Manufacturers in
Table Manufacturing Plants Distribution of Global Human Fibrinogen Major Manufacturers in
Table R&D Status and Technology Source of Global Human Fibrinogen Major Manufacturers in
Table Raw Materials Sources Analysis of Global Human Fibrinogen Major Manufacturers in
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Human Fibrinogen -E
Figure Global -E Human Fibrinogen Market Size (Volume) and Growth Rate
Figure Global -E Human Fibrinogen Market Size (Value) and Growth Rate
Table -E Global Human Fibrinogen Capacity and Growth Rate
Table Global Human Fibrinogen Capacity (MT) List (Company Segment)
Table -E Global Human Fibrinogen Sales (MT) and Growth Rate
Table Global Human Fibrinogen Sales (MT) List (Company Segment)
Table -E Global Human Fibrinogen Sales Price (USD/Kg)
Table Global Human Fibrinogen Sales Price (USD/Kg) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (MT) of Human Fibrinogen -E
Figure North America -E Human Fibrinogen Sales Price (USD/Kg)
Figure North America Human Fibrinogen Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (MT) of Human Fibrinogen -E
Figure Europe -E Human Fibrinogen Sales Price (USD/Kg)
Figure Europe Human Fibrinogen Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (MT) of Human Fibrinogen -E
Figure China -E Human Fibrinogen Sales Price (USD/Kg)
Figure China Human Fibrinogen Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (MT) of Human Fibrinogen -E
Figure Japan -E Human Fibrinogen Sales Price (USD/Kg)
Figure Japan Human Fibrinogen Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (MT) of Human Fibrinogen -E
Figure Southeast Asia -E Human Fibrinogen Sales Price (USD/Kg)
Figure Southeast Asia Human Fibrinogen Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (MT) of Human Fibrinogen -E
Figure India -E Human Fibrinogen Sales Price (USD/Kg)
Figure India Human Fibrinogen Sales Market Share
Table Global -E Human Fibrinogen Sales (MT) by Type
Table Different Types Human Fibrinogen Product Interview Price
Table Global -E Human Fibrinogen Sales (MT) by Application
Table Different Application Human Fibrinogen Product Interview Price
Table CSL Behring Information List
Table Product Overview
Table CSL Behring Human Fibrinogen Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg)
Figure CSL Behring Human Fibrinogen Business Region Distribution
Table LFB Information List
Table Product Overview
Table LFB Human Fibrinogen Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg)
Figure LFB Human Fibrinogen Business Region Distribution
Table Shanghai RAAS Information List
Table Product Overview
Table Shanghai RAAS Human Fibrinogen Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg)
Figure Shanghai RAAS Human Fibrinogen Business Region Distribution
Table Boya Information List
Table Product Overview
Table Boya Human Fibrinogen Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg)
Figure Boya Human Fibrinogen Business Region Distribution
Table Hualan Biological Engineering Information List
Table Product Overview
Table Hualan Biological Engineering Human Fibrinogen Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg)
Figure Hualan Biological Engineering Human Fibrinogen Business Region Distribution
Table Harbin Pacific Biopharmaceutical Information List
Table Product Overview
Table Harbin Pacific Biopharmaceutical Human Fibrinogen Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg)
Figure Harbin Pacific Biopharmaceutical Human Fibrinogen Business Region Distribution
Table Greencross Information List
Table Product Overview
Table Greencross Human Fibrinogen Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg)
Figure Greencross Human Fibrinogen Business Region Distribution
Table Shanghai XinXing Medical Information List
Table Product Overview
Table Shanghai XinXing Medical Human Fibrinogen Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg)
Figure Shanghai XinXing Medical Human Fibrinogen Business Region Distribution
Figure Global -2025 Human Fibrinogen Market Size (MT) and Growth Rate Forecast
Figure Global -2025 Human Fibrinogen Market Size (Million USD) and Growth Rate Forecast
Figure Global -2025 Human Fibrinogen Sales Price (USD/Kg) Forecast
Figure North America -2025 Human Fibrinogen Consumption Volume (MT) and Growth Rate Forecast
Figure China -2025 Human Fibrinogen Consumption Volume (MT) and Growth Rate Forecast
Figure Europe -2025 Human Fibrinogen Consumption Volume (MT) and Growth Rate Forecast
Figure Southeast Asia -2025 Human Fibrinogen Consumption Volume (MT) and Growth Rate Forecast
Figure Japan -2025 Human Fibrinogen Consumption Volume (MT) and Growth Rate Forecast
Figure India -2025 Human Fibrinogen Consumption Volume (MT) and Growth Rate Forecast
Table Global Sales Volume (MT) of Human Fibrinogen by Type -2025
Table Global Consumption Volume (MT) of Human Fibrinogen by Application -2025
Table Traders or Distributors with Contact Information of Human Fibrinogen by Region
Human Fibrinogen Concentrate (Lyophilized): The gold standard for rapid restoration of fibrinogen levels in acute bleeding.
Fibrin Sealant Kits: Dual-component systems (Fibrinogen + Thrombin) used for topical hemostasis and tissue sealing.
Purified Plasma-derived Fibrinogen: Used primarily in research and specialized clinical diagnostics.
Congenital Fibrinogen Deficiency: Treatment for rare disorders such as Afibrinogenemia and Hypofibrinogenemia.
Acquired Fibrinogen Deficiency (Trauma & Surgery): The fastest-growing segment, used in cardiac surgery, postpartum hemorrhage (PPH), and orthopedic procedures.
Liver Disease & Critical Care: Management of coagulopathy in patients with end-stage liver disease.
North America: Holds the largest revenue share due to high diagnosis rates for bleeding disorders and advanced surgical infrastructures in the US and Canada.
Europe: A mature market led by industry giants like CSL Behring and LFB. Strong emphasis on "Patient Blood Management" (PBM) protocols drives steady demand.
China: Represents the most significant growth opportunity. Large-scale domestic players (Shanghai RAAS, Hualan Bio) are expanding plasma collection capacities to meet localized demand.
Asia-Pacific (Ex-China): Significant growth in India and Southeast Asia due to rising surgical volumes and improving healthcare access.
Upto 24 to 48 hrs (Working Hours)
Upto 72 hrs max (Working Hours) - Weekends and Public Holidays
Single User License - Allows access to only one person to the report.
Multi User License - Allows sharing with max 5 persons within organization.
Corporate License – Can be shared across entire organization.
Online Payments with PayPal
Wire Transfer / Bank Transfer
At ChemReports, we understand that business decisions can’t wait. Our research specialists are available anytime to answer your queries and guide you through our reports, ensuring quick and reliable assistance.
ChemReports provides 360° market analysis across materials, technologies, and global chemical sectors—helping you make confident business decisions.
We turn complex data into strategic insights to support fact-based decisions, market entry strategies, and competitive analysis.
Your personal and business information is completely secure with us. We value your trust and ensure strict confidentiality.
Need tailored insights? Our analysts provide custom reports built on authentic data and aligned with your specific business goals.